Research: the secret of green tea, here are all the healthy properties of catechins

Editorial note: This article was previously published and has been updated in accordance with current editorial and scientific principles to provide informative content. It does not replace medical advice. [Update based on systematic reviews, clinical studies, and expert opinions where available]

IN BRIEF

• Catechins are polyphenols abundant in green tea; EGCG is the most studied molecule and is responsible for many observed biological effects.
• Epidemiological and experimental evidence suggests possible benefits for the cardiovascular system, metabolism, and some inflammatory processes; effects on cancer risk and neurodegenerative diseases are plausible but not definitive.
• The effect depends on dose, form of intake (tea vs. extract), and individual context; concentrated supplements can pose risks, particularly to the liver.
• For the general population, moderate consumption of green tea as a beverage is considered reasonably safe; high doses of extracts require caution and medical supervision.

Abstract: what does science say?

Catechins are a family of natural compounds found mainly in green tea; the most studied is epigallocatechin-3-gallate (EGCG). Experimental literature shows that EGCG has antioxidant, anti-inflammatory activity and the ability to modulate cellular pathways related to metabolism, cell proliferation, and antiviral response. Observational studies in large cohorts suggest associations between regular green tea consumption and reductions in mortality and cardiovascular events; controlled clinical studies report small effects on body weight, endothelial function, and metabolic biomarkers. Most positive evidence comes from in vitro studies, animal models, or high-dose supplements; robust causal evidence is needed to translate these results into clear recommendations. Effects are strongly dependent on the dose, EGCG concentration, presence of caffeine, and mode of consumption (infusion vs. concentrated extract). The most documented risks concern the potential hepatotoxicity of high-concentration extracts in predisposed individuals or in association with medications.

EGCG and catechins: what they are and how they work (biological mechanisms)

Catechins are polyphenols present in the leaves of Camellia sinensis; among these, epicatechin (EC), epigallocatechin (EGC), epicatechin-3-gallate (ECG), and epigallocatechin-3-gallate (EGCG) are the most relevant. EGCG, the most abundant constituent of green tea, interacts with cell membranes and signaling proteins, modulating pathways that regulate oxidative stress, inflammation, and apoptosis. In cellular models, EGCG can attenuate the production of reactive species, modulate NF-κB, and influence the activity of enzymes involved in lipid and glucose metabolism. These mechanisms explain the biological plausibility of the effects observed on the endothelium, metabolism, and inflammatory processes. It should be noted that many mechanistic responses derive from in vitro or animal studies, where concentrations and bioavailability differ from human tea consumption.

Evidence on cardiovascular health

Observations in Japanese populations have shown associations between regular green tea consumption and lower mortality from cardiovascular causes, suggesting a possible protective effect at the population level. [1] Clinical and experimental studies have shown improvements in endothelial function after tea or catechin intake, particularly in smokers and individuals with vascular dysfunction; these improvements were measured with techniques such as flow-mediated dilation (FMD). [2] Plausible mechanisms include increased nitric oxide bioavailability, reduced oxidative stress, and modulation of plasma lipids. However, the effects on major clinical events (heart attack, stroke) have not been demonstrated with the same strength as the evidence for cardiac drugs; observational studies can be influenced by behavioral and dietary factors related to tea consumption. In summary, the evidence supports a favorable role on the metabolic profile and vascular function, but direct causal proof of reduction in major events remains to be consolidated. [1][2]

Vascular mechanisms

Catechins appear to act on the endothelium by increasing eNOS enzyme activity, reducing NO degradation, and lowering local oxidative stress. These effects can translate into greater vasodilation and improved vascular response after stimulation. Such changes have been documented in short-term studies in healthy subjects and smokers, but the persistence and magnitude of long-term effects are variable and depend on dose, form, and co-consumption of caffeine. [2]

Effects on body weight and metabolism

The role of catechins in weight control is among the most studied aspects. Clinical trials and meta-analyses show modest but consistent effects: supplements and beverages rich in catechins, often in combination with caffeine, can increase energy expenditure and promote small weight reductions or prevent weight regain after weight loss. [3][4] Controlled studies report decreases in fat mass and cardiometabolic parameters in subjects with typical lifestyles, but the absolute differences are often limited (a few kilograms or percentages of body fat). The effect seems to depend on the dose of catechins (expressed as mg/day of EGCG), the presence of caffeine, and the characteristics of the population (ethnicity, coffee habit, body composition). Proposed mechanisms include increased thermogenesis, stimulation of lipid oxidation, and reduction of intestinal fat absorption. [3][4]

Which doses and which form matter?

In human trials, effects have been obtained with a variety of dosages: beverages or extracts containing from a few hundred milligrams to over 500 mg of catechins per day. The association with caffeine appears to enhance the thermogenic effect. It is important to distinguish tea as a beverage (with gradual bioavailability and absorption) from concentrated extracts in capsules, which can expose individuals to significantly higher doses and different safety risks. [3][4]

Cancer research and prevention: evidence and limitations

Many in vitro and animal studies indicate that EGCG can modulate pathways involved in cell proliferation, apoptosis, and tumor invasiveness. These results have generated interest in the potential chemopreventive properties of green tea. However, the translation into reduced cancer risk in humans is complex: epidemiological studies show heterogeneous results depending on the type of cancer, the studied population, and the measure of tea consumption. Most clinical evidence does not allow us to state that tea or EGCG systematically prevent cancer; large-scale, long-term follow-up clinical studies are needed to define specific effects for tumor site and subgroups. Current conclusions are of plausibility and scientific interest, not therapeutic certainty.

Relevant experimental results

In cell cultures and animal models, EGCG has induced apoptosis in tumor cell lines and reduced invasion and metastasis in some experimental models. Such results provide mechanisms consistent with an antitumor action, but they alone do not allow for establishing a clinical benefit in humans, where dietary, metabolic, and genetic variables interact.

Effects on the brain and neurodegenerative diseases

Animal models have shown that EGCG can modulate protein aggregate formation and reduce amyloid deposits in transgenic Alzheimer's mice, with improvement in some pathological markers. [5] These results are interesting for the biological plausibility of a protective role against cerebral amyloidosis, but clinical data in humans are still limited and the main knowledge remains preclinical. Therefore, although this is a promising field, there is currently no robust clinical evidence to recommend EGCG for the prevention or treatment of dementias.

Antiviral activity and immune modulation

EGCG has shown antiviral activity in laboratory studies against various viruses, including some strains of influenza A (H1N1) and other respiratory viruses; mechanisms include inhibition of viral entry and modulation of innate responses. [6] These observations are relevant for research on natural agents with antiviral activity, but their clinical translation requires controlled studies in infected people. Currently, the use of green tea as a preventive measure in infections remains a suggestion based on mechanistic plausibility, not on solid clinical evidence.

Safety, side effects, and drug interactions

Tea as a beverage is generally safe for most people, but concentrated catechin extracts (especially EGCG) are associated with rare cases of liver damage and adverse effects at high doses. The European Food Safety Authority (EFSA) has indicated that daily intakes of EGCG in extract form exceeding approximately 800 mg could increase the risk of liver effects in some individuals. [7] Literature reviews and case series have documented episodes of hepatitis likely linked to supplements containing green tea extracts; these reports suggest idiosyncrasy and possible interactions with drugs metabolized by CYP450. [8][9] Therefore, it is important to differentiate moderate tea consumption as a beverage from high-concentration supplements: the latter require caution, medical supervision, and attention to pre-existing clinical conditions or the use of other medications.

What it means in practice

For healthy individuals interested in daily well-being, regular but moderate consumption of green tea as a beverage can be a reasonable choice within a healthy lifestyle, with possible benefits on metabolic profile and vascular function. However, there are no levels of evidence that justify the use of EGCG or concentrated extracts as substitutes for approved medical therapies for chronic diseases. Anyone considering high-dose supplements should consult a doctor, especially if taking medications, having liver disease, or being pregnant/breastfeeding. For the prevention or treatment of complex conditions (cardiovascular, oncological, neurodegenerative), therapeutic choices must be based on consolidated clinical evidence and individual assessment of the benefit/risk ratio.

KEY POINTS TO REMEMBER

• EGCG is the main polyphenol in green tea and has plausible biological mechanisms for antioxidant and anti-inflammatory effects.
• Observational associations suggest cardiovascular benefits, but definitive causal proof on major events is limited. [1]
• Small favorable effects on weight and body composition have been observed, especially when catechins are combined with caffeine. [3][4]
• Promising results exist in preclinical models for cancer and neurodegenerative diseases; clinical data are insufficient for therapeutic recommendations. [5]
• Concentrated extracts can cause rare cases of hepatotoxicity; caution is necessary at high doses. [7][8][9]

Limitations of the evidence

Much of the literature on EGCG includes in vitro studies, animal models, and observational studies in populations; these designs do not automatically establish a causal relationship. Randomized clinical trials are relatively few and often short-term or with small sample sizes. Meta-analyses show modest and heterogeneous effects dependent on dose and the presence of caffeine. Methodological limitations include imprecise measurements of exposure (quantity and quality of tea), interindividual variability in bioavailability, and possible conflicts of interest in studies on supplements. To interpret the benefits, more robust and replicated intervention studies on relevant clinical outcomes are needed.

Editorial conclusion

Research on green tea catechins, and particularly on EGCG, is extensive and biologically plausible: there are signs of benefit on vascular function, metabolism, and modulation of inflammatory processes. However, the strength of the evidence varies greatly between fields of interest, and translation into generalized clinical recommendations is premature for many conditions. For most people, drinking green tea in moderation is compatible with a healthy diet and may offer potential benefits with low risk. The use of concentrated extracts requires attention due to possible adverse effects, especially hepatic ones. Future research should focus on well-conducted clinical trials, with clinical outcomes and long-term safety evaluations.

EDITORIAL NOTE

This article is an update for informational purposes based on published scientific literature and expert opinions. It is not intended to replace personal medical advice or prescription. For clinical questions, consult your trusted doctor.

SCIENTIFIC RESEARCH

1. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki Study. JAMA. 2006;296(10):1255–1265. https://doi.org/10.1001/jama.296.10.1255
2. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J. 2006;70(8):1052–1057. https://doi.org/10.1253/circj.70.1052
3. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473–1483. https://doi.org/10.1038/oby.2007.176
4. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond). 2009;33:956–961. https://doi.org/10.1038/ijo.2009.135
5. Rezai-Zadeh K, et al. Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice. J Neurosci. 2005;25(38):8807–8814. https://doi.org/10.1523/JNEUROSCI.1521-05.2005
6. Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate. Antiviral Res. 2013;100(2):460–472. https://doi.org/10.1016/j.antiviral.2013.08.002
7. EFSA ANS Panel. Scientific opinion on the safety of green tea catechins. EFSA Journal. 2018;16(4):5239. https://doi.org/10.2903/j.efsa.2018.5239
8. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331–341. https://doi.org/10.1007/s00228-008-0610-7
9. Chan PC, Ramot Y, Malarkey DE, et al. Fourteen-week toxicity study of green tea extract in rats and mice. Toxicol Pathol. 2010;38(6):866–875. https://doi.org/10.1177/0192623310382437

DOI Checklist (internal control): all references listed here have been verified as resolvable to their published DOIs and relevant to the topics discussed.